AcuityMD Raises $80M Series C for MedTech AI Platform

AcuityMD, a prominent artificial intelligence platform tailored for the medical technology sector, has successfully closed an $80 million Series C funding round. This significant capital infusion is earmarked to enhance its AI capabilities and accelerate the adoption of innovative medical devices and solutions globally.

The financing was spearheaded by existing investor StepStone Group, demonstrating continued confidence in the company's trajectory. Further backing came from a strong syndicate of venture capital firms, including Benchmark, Redpoint Ventures, ICONIQ, and Atreides Management. This latest funding brings AcuityMD's total capital raised to over $160 million, propelling its valuation to an impressive $955 million.

AcuityMD's platform is designed to empower commercial teams within the MedTech industry. By leveraging real-world healthcare data and sophisticated AI algorithms, the company helps organizations pinpoint target markets, identify high-potential sales opportunities, and ultimately drive business growth. Its technology assists companies across the entire product lifecycle, from pre-commercial stages to established enterprises, in understanding optimal sales strategies and expediting the integration of new medical technologies into clinical practice.

The impact of AcuityMD's solution is substantial. The company reports that its platform currently supports 16 of the top 20 medical technology firms and has been instrumental in helping its clients uncover more than $34 billion in potential sales pipeline. This track record underscores the critical role AI is playing in optimizing commercial operations within the complex and rapidly evolving MedTech market, a sector projected for continued expansion driven by technological advancements and an aging global population.

This funding round solidifies AcuityMD's position as a leader in the healthtech AI space. The company's recognition on Forbes' 2025 'Next Billion-Dollar Startups' list further validates its innovative approach and market potential. The MedTech sector, valued at hundreds of billions of dollars globally, is increasingly reliant on data-driven insights to navigate regulatory hurdles, understand physician needs, and streamline market access for life-saving innovations.

The strategic deployment of this capital is expected to fuel further product development, focusing on deepening AI integration for predictive analytics and customer engagement. AcuityMD's success highlights a broader trend of significant investment flowing into AI-powered solutions that address specific industry challenges, promising to reshape how medical technologies are brought to market and adopted by healthcare providers.